Posts by: Magdalena Kegel

Magdalena Kegel

Magdalena holds an MSc in Pharmaceutical Bioscience and an interdisciplinary PhD merging the fields of psychiatry, immunology and neuropharmacology. Her previous research focused on metabolic and immunologic changes in psychotic disorders. She is now focusing on science writing, allowing her to culture her passion for medical science and human health.

September 7, 2017

PSA Screening Lowers Mortality, Analysis of Clinical Trials Concludes

News

Prostate cancer screening using prostate-specific antigen (PSA) does reduce mortality in prostate cancer, according to a review that used a new approach to analyze data from large clinical trials. The ... Read more

August 16, 2017August 16, 2017

Hormone Therapy Delay Fails to Decrease Prostate Cancer Patients’ Quality of Life, Study Reports

News

After treating a man for prostate cancer, doctors pay close attention to whether levels of the disease’s main biomarker begin rising — an indication that the cancer has returned. Rising ... Read more

August 2, 2017

FDA Accepts Marketing Application for Churchill’s Yonsa Microsize Tablets for Advanced Prostate Cancer

News

The U.S. Food and Drug Administration (FDA) has accepted a New Drug Application (NDA) for Yonsa (abiraterone acetate) ultramicrosize tablets for the treatment of castration resistant prostate cancer that has ... Read more

July 11, 2017

Half of Urologists Unaware of New, More Sensitive Prostate Cancer Tests, Survey Shows

News

Half of urologists are unaware of newer, more sensitive biomarker tests for detecting prostate cancer, according to a survey of 300 of the specialists worldwide. The new tests reduce the ... Read more

July 6, 2017

Frequent Ejaculation May Protect Men from Low-risk Prostate Cancer

News

Men who ejaculate at least 21 times a month have a lower risk of prostate cancer compared to men who only ejaculate four to seven times a month, according to ... Read more

July 5, 2017July 5, 2017

Prostate Cancer Screening Benefits Depend on Men’s View of Treatment Side Effects

News

The benefits of prostate cancer screening are most evident in men with a family history of prostate cancer, according to a study that simulated the benefits and harms of screening under ... Read more

June 19, 2017

Modra Pharmaceuticals Starts Phase 2 Trial of Oral Docetaxel in Metastatic Prostate Cancer

News

Modra Pharmaceuticals has enrolled its first patient in a Phase 2 clinical trial (NCT03136640) of ModraDoc006/r as a treatment for metastatic castration-resistant prostate cancer — an advanced and often fatal ... Read more

May 15, 2017

New Imaging Agent Shown to Detect Aggressive Prostate Cancer in Mouse Study

News

A new imaging agent appears capable of distinguishing aggressive from benign prostate cancer, potentially helping doctors select with better precision those patients in need of more extensive treatment, a pre-clinical ... Read more

May 12, 2017

SBRT Shows Favorable Long-Term Outcomes and Low Severe Toxicity in Studies

News

Stereotactic body radiotherapy (SBRT) has shown good long-term outcomes and low rates of severe toxicity, making it a valid treatment option for men with low- and intermediate-risk prostate cancer, according to three ... Read more

May 10, 2017May 10, 2017

3 Professional Societies Issue Joint Guidelines for Prostate Cancer Care

News

Three professional societies — the American Urological Association, the American Society for Radiation Oncology and the Society of Urologic Oncology — have issued a series of evidence-based clinical guidelines on how to manage localized prostate cancer. ... Read more